Pioglitazone and Risk of Chronic Obstructive Pulmonary Disease in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study

CHIN-HSIAO TSENG2022-06-242022-06-2420221178-2005https://scholars.lib.ntu.edu.tw/handle/123456789/613314Pioglitazone's effect on chronic obstructive pulmonary disease (COPD) has rarely been studied.enTaiwan; chronic bronchitis; emphysema; pharmacoepidemiological study; risk factors; thiazolidinediones[SDGs]SDG3Pioglitazone and Risk of Chronic Obstructive Pulmonary Disease in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Studyjournal article10.2147/COPD.S345796351778992-s2.0-85124775509WOS:000754223900002https://scholars.lib.ntu.edu.tw/handle/123456789/597449